首站-论文投稿智能助手
典型文献
Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics
文献摘要:
Colorectal cancer(CRC),a malignant tumor worldwide consists of microsatellite instability(MSI)and stable(MSS)phenotypes.Although SHP2 is a hopeful target for cancer therapy,its relation-ship with innate immunosuppression remains elusive.To address that,single-cell RNA sequencing was performed to explore the role of SHP2 in all cell types of tumor microenvironment(TME)from murine MC38 xenografts.Intratumoral cells were found to be functionally heterogeneous and responded signif-icantly to SHP099,a SHP2 allosteric inhibitor.The malignant evolution of tumor cells was remarkably arrested by SHP099.Mechanistically,STING-TBKl-IRF3-mediated type Ⅰ interferon signaling was highly activated by SHP099 in infiltrated myeloid cells.Notably,CRC patients with MSS phenotype ex-hibited greater macrophage infiltration and more potent SHP2 phosphorylation in CD68+macrophages than MSI-high phenotypes,suggesting the potential role of macrophagic SHP2 in TME.Collectively,our data reveals a mechanism of innate immunosuppression mediated by SHP2,suggesting that SHP2 is a promising target for colon cancer immunotherapy.
文献关键词:
作者姓名:
Jian Gao;Zhigui Wu;Mingxia Zhao;Rui Zhang;Manru Li;Dongdong Sun;Haibo Cheng;Xianjia Qi;Yuxian Shen;Qiang Xu;Hongqi Chen;Dijun Chen;Yang Sun
作者机构:
State Key Laboratory of Pharmaceutical Biotechnology,Chemistry and Biomedicine Innovation Center(ChemBIC),School of Life Sciences,Nanjing University,Nanjing 210023,China;Biopharmaceutical Research Institute,School of Basic Medical Sciences,Anhui Medical University,Hefei 230032,China;Department of Colorectal Surgery,Cancer Hospital of China Medical University,Liaoning Cancer Hospital & Institute,Shenyang 110042,China;The First Clinical College of Nanjing University of Chinese Medicine,Nanjing 210023,China;Shanghai XuRan Biotechnology Co.,Ltd.,Shanghai 201109,China;Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy,Xuzhou Medical University,Xuzhou 221004,China;Department of General Surgery,Shanghai Jiao Tong University Affiiliated Sixth People's Hospital,Shanghai 200233,China
引用格式:
[1]Jian Gao;Zhigui Wu;Mingxia Zhao;Rui Zhang;Manru Li;Dongdong Sun;Haibo Cheng;Xianjia Qi;Yuxian Shen;Qiang Xu;Hongqi Chen;Dijun Chen;Yang Sun-.Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics)[J].药学学报(英文版),2022(01):149-166
A类:
SHP099,TBKl,CD68+macrophages,macrophagic
B类:
Allosteric,inhibition,reveals,SHP2,mediated,immunosuppression,colon,cancer,by,single,transcriptomics,Colorectal,CRC,malignant,worldwide,consists,microsatellite,instability,MSI,stable,MSS,phenotypes,Although,hopeful,target,its,relation,ship,innate,remains,elusive,To,address,that,sequencing,was,performed,explore,role,microenvironment,TME,from,murine,MC38,xenografts,Intratumoral,cells,were,found,be,functionally,heterogeneous,responded,signif,icantly,allosteric,inhibitor,evolution,remarkably,arrested,Mechanistically,STING,IRF3,interferon,signaling,highly,activated,infiltrated,myeloid,Notably,patients,hibited,greater,infiltration,more,phosphorylation,than,suggesting,potential,Collectively,our,data,mechanism,promising,immunotherapy
AB值:
0.554132
相似文献
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
ZNF3 regulates proliferation,migration and invasion through MMP1 and TWIST in colorectal cancer
Le Du;Ning Liu;Jianfeng Jin;Meng Cao;Yuantian Sun;Xinzheng Gao;Banzhan Ruan;Shangfeng Yang;Dongsheng Ge;Yingzhuan Ye;Yinxi Zhou;Erfei Chen;Jin Yang-Hainan Provincial Key Laboratory of Carcinogenesis and Intervention;Department of Biology,Hainan Medical University,Haikou 571199,China;Department of Gastrointestinal Surgery,Hainan General Hospital,Hainan Affiliated Hospital of Hainan Medical University,Haikou 571199,China;Department of Biochemistry and Molecular Biology,Hainan Medical University,Haikou 571199,China;College of Biomedical Information and Engineering,Hainan Medical University,Haikou 571199,China;Key Laboratory of Resources Biology and Biotechnology in Western China,Ministry of Education,College of Life Sciences,Northwest University,Xi'an 710069,China
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
Jingjing He;Xinxin Xiong;Han Yang;Dandan Li;Xuefei Liu;Shuo Li;Shuangye Liao;Siyu Chen;Xizhi Wen;Kuai Yu;Lingyi Fu;Xingjun Dong;Kaiyu Zhu;Xiaojun Xia;Tiebang Kang;Chaochao Bian;Xiang Li;Haiping Liu;Peirong Ding;Xiaoshi Zhang;Zhenjiang Liu;Wende Li;Zhixiang Zuo;Penghui Zhou-State Key Laboratory of Oncology in Southern China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou,China;Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,China;Guangdong Laboratory Animals Monitoring Institute,Guangdong Key Laboratory of Laboratory Animals,Guangzhou,China;Guangzhou Finelmmune Biotechnology Co.,LTD,Guangzhou,China
Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice
Qiu-yan Zhang;Su-jing Xu;Jian-chang Qian;Li-bin Yang;Peng-qin Chen;Yi Wang;Xiang Hu;Ya-li Zhang;Wu Luo;Guang Liang-Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China;Medical Research Center,The First Affiliated Hospital,Wenzhou Medical University,Wenzhou 325035,China;School and Hospital of Stomatology,Wenzhou Medical University,Wenzhou 325027,China;Department of Endocrinology,The First Affiliated Hospital,Wenzhou Medical University,Wenzhou 325035,China;School of Pharmaceutical Sciences,Hangzhou Medical College,Hangzhou 311399,China;Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。